DFS
59
5
HRL
35
-3
PNW
63
-3
MRK
50
-3
RRC
52
2
A
46
3
MAC
61
7
SIG
60
2
IRM
68
-3
MKC
59
-3
MTCH
48
4
CL
56
-2
ES
53
-2
MAT
54
3
CMS
64
-3
UA
24
-9
NDAQ
63
4
DHR
60
4
HBAN
48
3
CHK
35
8
DFS
59
5
HRL
35
-3
PNW
63
-3
MRK
50
-3
RRC
52
2
A
46
3
MAC
61
7
SIG
60
2
IRM
68
-3
MKC
59
-3
MTCH
48
4
CL
56
-2
ES
53
-2
MAT
54
3
CMS
64
-3
UA
24
-9
NDAQ
63
4
DHR
60
4
HBAN
48
3
CHK
35
8
Financhill
Back

Compugen Vs. Can Fite Biofarma Industry Stock Comparison

Sell
30

CGEN
Compugen

Last Price:
1.84
Seasonality Move:
-8.19%
Sell
42

CANF
Can Fite Biofarma

Last Price:
2.04
Seasonality Move:
6.52%
Sell
30
Compugen (CGEN) is a Sell

Is Compugen a Buy, Sell or Hold?

  • The current Compugen [CGEN] share price is $1.84. The Score for CGEN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CGEN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Can Fite Biofarma (CANF) is a Sell

Is Can Fite Biofarma a Buy, Sell or Hold?

  • The current Can Fite Biofarma [CANF] share price is $2.02. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CANF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CGEN Stock Price Chart

What is Compugen's stock price today?

  • The Compugen share price today is $1.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CGEN is experiencing selling pressure, which indicates risk of future bearish movement.

CANF Stock Price Chart

What is Can Fite Biofarma's stock price today?

  • The Can Fite Biofarma share price today is $2.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing selling pressure, which indicates risk of future bearish movement.

CGEN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 46 Sell
Chaikin Money Flow: -111058 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.85 - 2.01) Sell
Bollinger Bands (100): (1.74 - 2.12) Sell

CANF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 34.24 Sell
Chaikin Money Flow: -73763 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.19 - 2.43) Sell
Bollinger Bands (100): (2.12 - 3.14) Sell

CGEN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.92 Sell
20-day SMA: 1.95 Sell
50-day SMA: 1.85 Sell
200-day SMA: 2 Sell
8-day EMA: 1.9 Sell
20-day EMA: 1.91 Sell
50-day EMA: 1.89 Sell
200-day EMA: 1.84 Sell

CANF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.27 Sell
20-day SMA: 2.28 Sell
50-day SMA: 2.77 Sell
200-day SMA: 2.37 Sell
8-day EMA: 2.21 Sell
20-day EMA: 2.32 Sell
50-day EMA: 2.52 Sell
200-day EMA: 2.59 Sell

Compugen Earnings Growth & CGEN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and a decrease next year of $0.31 per share.

Can Fite Biofarma Earnings Growth & CANF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.38 per share, and an increase next year of $0.04 per share.

Compugen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Can Fite Biofarma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):